But US authorities recently made an advance purchase of 1.7 million ... also made purchase agreements. Merck is the first company to report trial results of a pill to treat Covid, but other ...
U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients. Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent ...
Earlier this year, the Sun Pharma had signed a non-exclusive voluntary licensing agreement with US-based Merck to manufacture ... advantage as it reduces the pill burden and enhances compliance.
Merck is the first company to report trial results of a pill to treat Covid ... molnupiravir by the end of 2021. The US government has already agreed to buy $1.2bn (£885m) worth of the drug ...
The move comes after Merck filed for emergency approvals of molnupiravir in the US, Europe and Canada on the back of clinical trial data showing it was able to halve the risk of hospitalisation or ...
Sales of Merck's Covid antiviral pill, Lagevrio, also fell 40% to $383 million during the quarter. Still, that topped ...
Merck – which has also filed for approval of its drug in Canada – has already sold 1.7 million treatment courses to the US government, and says other deals are being negotiated. It expects to ...
WASHINGTON--A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck ... the government’s purchase agreement with Merck for 3.1 million courses ...